A Missouri judge on Friday approved Bayer’s $7.25bn settlement of lawsuits alleging its weedkiller Roundup causes cancer, potentially resolving litigation that has weighed on the German company for close to a decade.
Judge Timothy Boyer of a state court in St Louis found the settlement “fair, reasonable and adequate”. He rejected objections that payments to individual cancer victims would be too low compared with amounts paid to claimants who had previously settled.
Boyer also said delaying payments could force victims, including those with terminal cancer, to wait “an indeterminate number of years” to be paid.
Bayer had faced approximately 65,000 claims in US state and federal courts from people who said they developed cancer after using Roundup at home or at work. The settlement, announced in February, was intended to resolve nearly all current and future Roundup claims in the US.
“The court’s final approval is a decisive milestone in the company’s strategy to mitigate the risks of both pending and future Roundup litigation,” Bayer CEO Bill Anderson said in a statement.
Bayer has faced extensive litigation over Roundup, and its share price has fallen 46% since the company bought Monsanto, which produces the weedkiller, for $63bn in 2018. Bayer settled much of the Roundup litigation for $10.9bn in 2020, but could not win court approval for a $1.25bn settlement covering future claims.
Bayer has long maintained that Roundup and its active ingredient, glyphosate, are safe, and that decades of studies have shown glyphosate does not cause cancer.
The settlement was approved five months after the US supreme court overturned a $1.25m jury award to Missouri man John Durnell, who blamed years of exposure to glyphosate in Roundup for his non-Hodgkin lymphoma. In a 7-2 decision, the court agreed with Bayer that a federal law regulating pesticides barred failure-to-warn claims under state law, weakening a central pillar of many lawsuits.
Christopher Seeger, a lawyer for many of the plaintiffs, said the Durnell decision narrowed Roundup victims’ ability to pursue claims in court. “We look forward to getting this relief into the hands of all Roundup victims as quickly as possible,” he said in a statement.
Lawyers for some Roundup victims who objected to the settlement did not immediately respond to requests for comment. The settlement excludes some lawsuits still pending in federal court. Bayer has said about 200 of those cases were still being litigated and that the supreme court decision gave it strong defenses.
